Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $12,853,171 | $11,286,078 | $8,949,838 | $16,724,420 |
| - Cash | $1,180,187 | $1,403,492 | $1,273,787 | $1,481,655 |
| + Debt | $11,004,224 | $12,077,287 | $13,212,572 | $13,320,149 |
| Enterprise Value | $22,677,208 | $21,959,873 | $20,888,623 | $28,562,914 |
| Revenue | $19,335,909 | $19,453,617 | $19,398,017 | $17,618,685 |
| % Growth | -0.6% | 0.3% | 10.1% | – |
| Gross Profit | $4,756,652 | $4,925,005 | $4,893,689 | $4,773,029 |
| % Margin | 24.6% | 25.3% | 25.2% | 27.1% |
| EBITDA | $3,206,227 | $3,209,626 | $3,417,781 | $3,549,136 |
| % Margin | 16.6% | 16.5% | 17.6% | 20.1% |
| Net Income | $537,913 | $498,997 | $673,405 | $969,308 |
| % Margin | 2.8% | 2.6% | 3.5% | 5.5% |
| EPS Diluted | 0.92 | 0.85 | 0.57 | 0.83 |
| % Growth | 8.2% | 49.1% | -31.3% | – |
| Operating Cash Flow | $2,386,144 | $2,628,801 | $2,167,379 | $2,489,498 |
| Capital Expenditures | -$699,358 | -$684,596 | -$723,988 | -$854,360 |
| Free Cash Flow | $1,686,786 | $1,944,205 | $1,443,391 | $1,635,138 |